NCT07794839Recruiting
Drug-coated Balloon Treatment
The Role of Drug Coated Balloons in the Treatment of Coronary Artery Disease: an Observational Nationwide Experience
Source: ClinicalTrials.gov · Last updated 31 Aug 2026
Brief summary (registry, in English)
Evaluation of the efficacy and clinical outcomes of drug-eluting balloon therapy in ticyaici coronary artery disease.
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 1000 (estimated)
- First submitted
- 26 Aug 2026
- Start date
- 1 Jan 2026
- Primary completion date
- 1 Jan 2027
- Lead sponsor
- Istanbul Mehmet Akif Ersoy Educational and Training Hospital
- Diseases
- Coronary artery disease
- NCT number
- NCT07794839
What you commit to
- Study type: Observational
- Planned participants: 1000
- From 1 Jan 2026 to the primary completion date, 1 Jan 2027
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| University of Health Sciences, Mehmet Akif Ersoy Thoracic and Cardiovascular Surgery Center, Training and Research Hospital, Department of Cardiology Coordinator of this site? Confirm its status | Istanbul | Turkey (Türkiye) | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.